You searched for partnering - Page 3 of 32

16 Décembre 2025 - 2 mn de lecture

Acquired Science. Accelerated Impact. Ipsen’s Determined M&A Strategy Is Rewriting the Rules of Innovation

Philippe Lopes-Fernandes, EVP & Chief Business Officer, shares how Ipsen’s tenacious approach to dealmaking is transforming breakthrough science into global impact—solidly....

- 18 Mai 2026

Ipsen initiates a new share buy-back program

Ipsen initiates a new share buy-back program...

- 22 Septembre 2025 - 2 mn de lecture

Building better processes, earlier: a chemist’s perspective on innovation and sustainability

...

- 01 Avril 2026

Ipsen announces the availability of its 2025 Universal Registration Document

Ipsen announces the availability of its 2025 Universal Registration Document...

- 07 Juillet 2026

Ipsen – Half year statement – 2026 06 30

Half-year statement of the liquidity agreement between IPSEN SA and NATIXIS ODDO BHF...

- 15 Décembre 2025

Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline

PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced it has completed the acquisition of ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies. ...